Literature DB >> 20936299

Financial and non-financial conflicts of interests in psychiatry.

Mario Maj1.   

Abstract

A conflict of interests occurs when a doctor is unduly influenced by a secondary interest (i.e., a personal incentive) in his acts concerning one of the primary interests to which he is professionally committed (the welfare of patients, the progress of science, or the education of students or residents). One specific variety of conflicts of interests has monopolized the attention of the scientific and lay press: the financial conflicts of interests arising from the relationships between doctors and drug companies. A large literature has described the many, sometimes subtle, ways by which a psychiatrist can be influenced in his prescribing habits or research activities by his relationships with the industry. Some empirical evidence is now available in this area. On the other hand, it has been pointed out that the current debate on this issue is sometimes "affectively charged" or fails to take into account that the interests of patients, families and mental health professionals and those of the industry may be often convergent. Other types of conflicts of interests are beginning now to be discussed. There is evidence that the allegiance of a researcher to a given school of thought may influence the results of studies comparing different psychotherapeutic techniques, thus colliding with the primary interest represented by the progress of science. Political commitment is also emerging as a source of conflicts of interests. Financial and non-financial conflicts of interests are widespread in psychiatric practice and research. They cannot be eradicated, but must be managed more effectively than is currently the case.

Entities:  

Mesh:

Year:  2010        PMID: 20936299     DOI: 10.1007/s00406-010-0131-0

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  23 in total

1.  Conflict of interest and special interest groups. The making of a counter culture.

Authors:  G A Fava
Journal:  Psychother Psychosom       Date:  2001 Jan-Feb       Impact factor: 17.659

2.  Relationships between authors of clinical practice guidelines and the pharmaceutical industry.

Authors:  Niteesh K Choudhry; Henry Thomas Stelfox; Allan S Detsky
Journal:  JAMA       Date:  2002-02-06       Impact factor: 56.272

3.  Lessons from psychotherapy research for psychological interventions for people with schizophrenia.

Authors:  Graham Paley; David A Shapiro
Journal:  Psychol Psychother       Date:  2002-03       Impact factor: 3.915

Review 4.  Design and reporting modifications in industry-sponsored comparative psychopharmacology trials.

Authors:  Daniel J Safer
Journal:  J Nerv Ment Dis       Date:  2002-09       Impact factor: 2.254

5.  Good publication practice for pharmaceutical companies.

Authors:  Elizabeth Wager; Elizabeth A Field; Leni Grossman
Journal:  Curr Med Res Opin       Date:  2003       Impact factor: 2.580

Review 6.  Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine: an exploratory analysis of head-to-head comparison studies of second-generation antipsychotics.

Authors:  Stephan Heres; John Davis; Katja Maino; Elisabeth Jetzinger; Werner Kissling; Stefan Leucht
Journal:  Am J Psychiatry       Date:  2006-02       Impact factor: 18.112

7.  On the propriety of collaborations between academicians and the pharmaceutical industry: an alternate viewpoint.

Authors:  Michael E Thase
Journal:  World Psychiatry       Date:  2007-02       Impact factor: 49.548

8.  Psychiatry: from interest in conflicts to conflicts of interest.

Authors:  Eduard Vieta
Journal:  World Psychiatry       Date:  2007-02       Impact factor: 49.548

9.  Financial conflicts of interest in psychiatry.

Authors:  Giovanni A Fava
Journal:  World Psychiatry       Date:  2007-02       Impact factor: 49.548

10.  Understanding financial conflicts of interest.

Authors:  D F Thompson
Journal:  N Engl J Med       Date:  1993-08-19       Impact factor: 91.245

View more
  1 in total

1.  Disclosures of conflicts of interest in psychiatric review articles.

Authors:  Andrew M Kopelman; David A Gorelick; Paul S Appelbaum
Journal:  J Nerv Ment Dis       Date:  2013-02       Impact factor: 2.254

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.